Patent · US Active

Compounds with activity at estrogen receptors

US8822548B2 · kind B2 · utility

0Cited by
17References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 29, 2010
Grant dateSep 2, 2014
Priority date
Expiry dateJan 26, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2602/24
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods of treatment and prevention of diseases and disorders related to estrogen receptors comprising administering novel di-aromatic compounds to patients in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.